Linzagolix with and without concomitant add-back therapy was associated with reductions in heavy menstrual bleeding in uterine fibroids.

ECHELON-3 is a randomized, double-blind, placebo-controlled, active-comparator ... patients after completion of one cycle of open-label BV + Len + R in the safety run-in period, which enrolled a total ...